Influenza symptoms and their impact on elderly adults: randomised trial of AS03-adjuvanted or non-adjuvanted inactivated trivalent seasonal influenza vaccines.

Autoria(s): van Essen,GA; Beran,J; Devaster,JM; Durand,C; Duval,X; Esen,M; Falsey,AR; Feldman,G; Gervais,P; Innis,BL; Kovac,M; Launay,O; Leroux-Roels,G; McElhaney,JE; McNeil,S; Oujaa,M; Richardus,JH; Ruiz-Palacios,G; Osborne,RH; Oostvogels,L
Data(s)

01/07/2014
Resumo

Patient-reported outcomes (PROs) are particularly relevant in influenza vaccine trials in the elderly where reduction in symptom severity could prevent illness-related functional impairment.
Identificador

http://hdl.handle.net/10536/DRO/DU:30067577
Idioma(s)

eng
Publicador

Wiley
Relação

http://dro.deakin.edu.au/eserv/DU:30067577/vanessen-iInfluenzasymptoms-2014.pdf

http://www.dx.doi.org/10.1111/irv.12245

http://www.ncbi.nlm.nih.gov/pubmed/24702710
Direitos

2014, Wiley
Palavras-Chave #AS03-adjuvanted vaccine #FluiiQ #elderly #influenza #patient-reported outcomes #Science & Technology #Life Sciences & Biomedicine #Infectious Diseases #Virology #UNITED-STATES #RESPONSES #EFFICACY #TIME #H5N1
Tipo

Journal Article
Acesso ao item digital